https://scholars.lib.ntu.edu.tw/handle/123456789/630786
標題: | Standardized home blood pressure monitoring: Rationale behind the 722 protocol | 作者: | HUNG-JU LIN HENG-YU PAN Chen, Chen-Huan Cheng, Hao-Min Chia, Yook-Chin Sogunuru, Guru Prasad Tay, Jam Chin Turana, Yuda Verma, Narsingh Kario, Kazuomi TZUNG-DAU WANG |
關鍵字: | CARDIOVASCULAR OUTCOMES; HYPERTENSIVE PATIENTS; TAIWAN HYPERTENSION; ATRIAL-FIBRILLATION; SELF-MEASUREMENT; GENERAL-PRACTICE; MORNING SURGE; OFFICE; SOCIETY; RISK | 公開日期: | 九月-2022 | 出版社: | WILEY | 卷: | 24 | 期: | 9 | 起(迄)頁: | 1161 | 來源出版物: | Journal of clinical hypertension (Greenwich, Conn.) | 摘要: | Home blood pressure (HBP) has been recognized as a prognostic predictor for cardiovascular events, and integrated into the diagnosis and management of hypertension. With increasing accessibility of oscillometric blood pressure devices, HBP monitoring is easy to perform, more likely to obtain reliable estimation of blood pressures, and feasible to document long-term blood pressure variations, compared to office and ambulatory blood pressures. To obtain reliable HBP estimates, a standardized HBP monitoring protocol is essential. A consensus regarding the optimal duration and frequency of HBP monitoring is yet to be established. Based on the current evidence, the "722" protocol, which stands for two measurements on one occasion, two occasions a day (morning and evening), and over a consecutive of 7 days, is most commonly used in clinical studies and recommended in relevant guidelines and consensus documents. HBP monitoring based on the "722" protocol fulfills the minimal requirement of blood pressure measurements to achieve agreement of blood pressure classifications defined by office blood pressures and to predict cardiovascular risks. In the Taiwan HBP consensus, the frequency of repeating the "722" protocol of HBP monitoring according to different scenarios of hypertension management, from every 2 weeks to 3 months, is recommended. It is reasonable to conclude that the "722" protocol for HBP monitoring is clinically justified and can serve as a basis for standardized HBP monitoring. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/630786 | ISSN: | 1524-6175 | DOI: | 10.1111/jch.14549 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。